The entry of the Rovati family and the manager-entrepreneur Sigieri Diaz della Vittoria into the limited partnership of Marco Tronchetti Provera goes through. The shareholders' meeting of Mtp Sapa approved the transformation into a joint-stock company and gave the green light to the 40 million capital increase functional to the entry of the two new shareholders to be carried out by 31 January next.
Rottapharm dei Rovati will subscribe 11.850 shares for 35,7 million, arriving at holding 25%, Diaz will subscribe 1.423 shares for 4,3 million in exchange for approximately 3%. The new Marco Tronchetti Provera & C. Spa, this is the name assumed by the vehicle after the transformation into a joint-stock company, will therefore see the Tronchetti family 69,2%, Rovati 25%, Diaz 3% and Federico Enrichetti's Milano Centro 2,7%.
With the investment, Luca Rovati and Sigieri Diaz will have a seat on the board of the company which, in addition to the president and their three children, also includes Giorgio Bruno and the lawyer Francesco Chiappetta.
